PD-1 Antibody for the Prevention of Adenomatous Polyps and Second Primary Tumors in Patients With Lynch Syndrome: An Open-label, Multicenter, Randomized Controlled Clinical Trial
Latest Information Update: 02 Nov 2021
At a glance
- Drugs Toripalimab (Primary)
- Indications Familial adenomatous polyposis; Hereditary nonpolyposis colorectal cancer; Rectal cancer
- Focus Therapeutic Use
- 19 Jan 2021 New trial record